Literature DB >> 11987768

Drug-induced lung injury.

Jeremy J Erasmus1, H Page McAdams, Santiago E Rossi.   

Abstract

Lung injury is an increasing cause of morbidity and mortality in patients treated with cytotoxic and noncytotoxic drugs. Prompt diagnosis is important because early drug-induced lung injury will often regress with the cessation of therapy. Diagnosis requires a high index of suspicion because infection, radiation pneumonitis, and recurrence of the underlying disease can manifest clinically and radiologically in a similar manner. Because the lungs have only a limited number of histopathologic responses to injury, including pulmonary edema/diffuse alveolar damage, NSIP, BOOP, EP, and pulmonary hemorrhage, knowledge of these manifestations and the corresponding radiologic manifestations can often be useful in suggesting a diagnosis of drug-induced lung injury. An understanding of the drugs most commonly associated with lung injury can also facilitate diagnosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11987768     DOI: 10.1053/sroe.2002.0000

Source DB:  PubMed          Journal:  Semin Roentgenol        ISSN: 0037-198X            Impact factor:   0.800


  11 in total

1.  Drug-associated acute lung injury: a population-based cohort study.

Authors:  Rajanigandha Dhokarh; Guangxi Li; Christopher N Schmickl; Rahul Kashyap; Jyoti Assudani; Andrew H Limper; Ognjen Gajic
Journal:  Chest       Date:  2012-10       Impact factor: 9.410

2.  Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.

Authors:  Silas W Smith; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2008-06

Review 3.  Drug-induced interstitial lung disease in molecular targeted therapies: high-resolution CT findings.

Authors:  Fumikazu Sakai; Takeshi Johkoh; Masahiko Kusumoto; Hiroaki Arakawa; Masahiro Takahashi
Journal:  Int J Clin Oncol       Date:  2012-11-10       Impact factor: 3.402

4.  Drug Induced Pneumonitis Secondary to Treatment with Paritaprevir/Ritonavir/Ombitasvir and Dasabuvir (VIEKIRA PAK®) for Chronic Hepatitis C: Case Report of an Unexpected Life-Threatening Adverse Reaction.

Authors:  Shih Yea Sylvia Wu; Bridget Faire; Edward Gane
Journal:  Case Rep Med       Date:  2017-03-20

5.  Ground glass pulmonary nodules: their significance in oncology patients and the role of computer tomography and 18F-fluorodeoxyglucose positron emission tomography.

Authors:  Laura Evangelista; Annalori Panunzio; Elena Scagliori; Paolo Sartori
Journal:  Eur J Hybrid Imaging       Date:  2018-02-26

6.  Effective ferroptotic small-cell lung cancer cell death from SLC7A11 inhibition by sulforaphane.

Authors:  Yuko Iida; Mayumi Okamoto-Katsuyama; Shuichiro Maruoka; Kenji Mizumura; Tetsuo Shimizu; Sotaro Shikano; Mari Hikichi; Mai Takahashi; Kota Tsuya; Shinichi Okamoto; Toshio Inoue; Yoko Nakanishi; Noriaki Takahashi; Shinobu Masuda; Shu Hashimoto; Yasuhiro Gon
Journal:  Oncol Lett       Date:  2020-11-25       Impact factor: 2.967

Review 7.  Diagnosis and management of drug-associated interstitial lung disease.

Authors:  N L Müller; D A White; H Jiang; A Gemma
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

Review 8.  [The Effects and Management of Viral Pneumonia on Lung Cancer Patients].

Authors:  Yanhong Yao; Ming Lu; Yan'e Liu; Baoshan Cao
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-03-26

Review 9.  Interstitial lung disease associated with drug therapy.

Authors:  P Camus; S Kudoh; M Ebina
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

10.  Interstitial lung disease in patients with non-small-cell lung cancer: causes, mechanisms and management.

Authors:  P Camus
Journal:  Br J Cancer       Date:  2004-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.